by telrheum | Mar 16, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis, Vaccines
The American College of Rheumatology (ACR) has issued recommendations regarding the use of COVID-19 booster vaccines for patients undergoing biologic therapy, a treatment often prescribed for various autoimmune conditions, such as rheumatoid arthritis, psoriatic...
by telrheum | Mar 13, 2024 | Osteoporosis
When it comes to maintaining our health, bones play a crucial role, acting as the framework of our body, protecting organs, anchoring muscles, and storing calcium. A bone density test, or DEXA scan, is a way to measure the strength and density of your bones. It’s like...
by telrheum | Mar 12, 2024 | Biologic Therapy, JAK Inhibitor, Rheumatic Drugs
Recent studies have hinted at the intriguing possibility that certain drugs used in the treatment of rheumatic diseases might also have beneficial effects in preventing or delaying the development of Alzheimer’s disease. This article delves into the emerging...
by telrheum | Mar 11, 2024 | JAK Inhibitor, Biologic Therapy, Colitis, Rheumatoid Arthritis, Spondyloarthritis
Rinvoq, a newer medication in the field of rheumatology and immunology, has shown remarkable efficacy in managing several chronic inflammatory conditions. As a selective Janus kinase (JAK) inhibitor, Rinvoq specifically targets pathways that contribute to the...
by telrheum | Mar 11, 2024 | Rheumatoid Arthritis, Colitis, JAK Inhibitor
Xeljanz, known generically as tofacitinib, is a medication that represents a significant advancement in the treatment of various autoimmune diseases. Approved by the FDA, Xeljanz operates by inhibiting Janus kinase (JAK) pathways, which are crucial in the process of...